Logo

Team

Researchers and investors working out which signals predict what happens to biotech companies and their drugs, and which only look like they do.

Gunner L. Hardy

Gunner L. Hardy

Co-Founder, Drug Development Research

LinkedIn

Gunner co-founded Contraview to measure how biotech science turns into value. He leads its work on exit prediction, clinical evidence and testing every model only on what was known at the time.

He trained in econometrics, Bayesian statistics and bioinformatics, including work that ran from RNA to genes to AlphaFold structure prediction and simulated protein interactions to annotate biosynthesis pathways.

He has invested in biotech and longevity at Conscience VC and Longevity Vision Fund, after banking and development finance at Bank of America Merrill Lynch, the EBRD and the World Bank. He holds master's degrees in biotechnology and in economics and finance.

Prateek Rajput

Prateek Rajput

Co-Founder, Machine Learning

LinkedIn

Prateek co-founded Contraview and leads its machine learning research, building its knowledge graph and retrieval systems.

He is a PhD researcher at the University of Luxembourg (SnT), where he studies whether code written by language models and coding agents is secure, stable and truly understood rather than memorised. His recent work includes TRACER, which uses an agent's own development history to find and repair security flaws, with papers at ICSE, ASE, LREC and AAAI symposia.

He previously did research and data science at Huawei and studied at IIT Kanpur.

Also committed to the research

Abiola Adeshina

Abiola Adeshina

LinkedIn ›

Compute and Infrastructure

Abiola scales Contraview's compute, moving its research and model-training workflows onto AWS as machine-learning demand grows. He built the backend API the platform runs on. He is an AI agent infrastructure engineer and the founder of OmniRexflora Labs in Lagos.

Want to work with us?

Investors, founders and researchers: we would like to hear from you.

Get in touch